PMID: 9169311Apr 1, 1997Paper

Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
M BoscV Polin

Abstract

The Social Adaptation Self-evaluation Scale (SASS) is a 21-item newly developed scale for the evaluation of patient social motivation and behaviour in depression. The scale was submitted to a validation procedure based on the data from a general population survey in 4000 individuals and from two controlled studies comparing the new selective noradrenaline reuptake inhibitor (NARI), reboxetine, with placebo and/or fluoxetine in 549 patients with major depression. The scale was shown to be valid, reliable and sensitive to change. The results of the multivariate analyses allowed the identification of three principal factors and five clusters. In view of its simplicity of use, and of its peculiar characteristic of investigating patient perspective on self and environment perception and on social motivation and behaviour, the scale represents a useful additional tool for the evaluation of social functioning in depression and will facilitate the development of new antidepressants with differential effects in this domain in depressed patients.

Associated Clinical Trials

References

Feb 1, 1979·Journal of Abnormal Psychology·W C Lobitz, R D Post
Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Sep 1, 1976·Archives of General Psychiatry·M M Weissman, S Bothwell
Mar 1, 1975·Archives of General Psychiatry·M M Weissman
Apr 1, 1976·Journal of Abnormal Psychology·J C Coyne
Apr 1, 1973·Journal of Consulting and Clinical Psychology·J M Libet, P M Lewinsohn
Jun 1, 1974·Archives of General Psychiatry·M M WeissmanB Hanson
Nov 1, 1980·Psychological Medicine·S HendersonR Scott
Nov 1, 1981·Archives of General Psychiatry·M M WeissmanK John
Apr 12, 1996·Journal of Affective Disorders·J B Leader, D N Klein
Mar 1, 1996·International Clinical Psychopharmacology·E SouêtreH Monteban
Apr 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A DubiniV Polin
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Sep 27, 2007·European Child & Adolescent Psychiatry·Nora S VyasSophia Frangou
Aug 29, 2012·Journal of Affective Disorders·C De DiosA García-López
Jan 26, 2000·Comprehensive Psychiatry·M Bosc
Jan 7, 2004·Journal of Affective Disorders·Myrna M WeissmanSteven Shea
Mar 23, 2000·Progress in Neurobiology·P GareriG De Sarro
Jul 6, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·H J Möller
Jun 22, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·G MainaF Bogetto
Feb 28, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·E HilgerS Kasper
Sep 5, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A J Bond
Sep 5, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·N BrunelloG Racagni
Apr 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A DubiniV Polin
Feb 22, 2000·Clinical Cornerstone·S H Kennedy, B S Eisfeld
May 12, 2007·Psychological Medicine·Stella W Y ChanCatherine J Harmer
Jan 31, 2013·Cognition & Emotion·Ana C García-BlancoLorenzo Livianos
Dec 14, 2011·Journal of Social Work in End-of-life & Palliative Care·Dona J Reese
Apr 2, 2009·Psychiatry and Clinical Neurosciences·Secondo FassinoPaolo Leombruni
Jul 14, 2011·Neuropsychiatric Disease and Treatment·Siegfried KasperAlexandra Kutzelnigg
Jan 27, 2007·Srpski arhiv za celokupno lekarstvo·Zana StankovićLjiljana Popović
Feb 19, 2005·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Gordana Dedić
Nov 3, 2007·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Lindsay McMahonR Hamish McAllister-Williams
Apr 18, 2002·Biological Psychiatry·Catherine J HarmerGuy M Goodwin
Jul 22, 2010·Psychiatry Research·Luis Gutiérrez-RojasManuel Gurpegui
Jul 10, 2002·Journal of Affective Disorders·C GorensteinL Andrade
Aug 9, 2002·Journal of Affective Disorders·Benedetto FarinaMassimo Di Giannantonio
Jun 26, 2010·Journal of Affective Disorders·Luis Gutiérrez-RojasManuel Gurpegui
Feb 24, 2009·Journal of Psychiatric Research·Edda PjrekDietmar Winkler
Mar 7, 2009·Journal of the Neurological Sciences·Rosario S SpadaJean-Louis Guéant
Nov 8, 2015·Psychiatry Research·Gordon ParkerDusan Hadzi-Pavlovic
Sep 8, 2015·Journal of Affective Disorders·Kaloyan KamenovJosé Luis Ayuso-Mateos
Nov 3, 2011·International Journal of Psychology : Journal International De Psychologie·Wai S TseJacky C K Cheung
Mar 23, 2011·Journal of Psychiatric and Mental Health Nursing·P D JönssonI Skärsäter
Dec 6, 2011·International Journal of Methods in Psychiatric Research·Marc J GameroffMyrna M Weissman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.